wall in Medical Technology

FDA Clears ExAblate Fertility Enhancement Study in Women With Uterine Fibroids

... rate of miscarriage. Unfortunately, since fibroids that have grown on the wall of the uterus need to be removed by myomectomy, a major abdominal ... 2004 European Union's Information Society Technologies grand prize, The wall Street Journal's 2004 Technology Innovation Awards, Advanced Imaging's ...

Preclinical Data Demonstrate Ability to Regenerate an Entire Bladder With Tengion Neo-Bladder Replacement(TM)

... cystography by six months after implantation -- The regenerated bladder wall structure consisted of three layers: urothelium, muscle, and serosa by ... two months after implantation -- The regenerated bladder wall showed near native pharmacological and electrophysiological functional ...

Neurointerventionists Expand Research to Quality of Life in Aneurysm Patients Following Minimally Invasive Coiling Treatment

... But while the efficacy of minimally invasive coiling has been proven many times over in the case of intracranial aneurysms (a bulge in the artery wall which can suddenly burst, leading to bleeding in the brain that may result in severe disability, or even death), less is known about the psychosocial ...

International Journal of Occupational and Environmental Health Features Discovery of Asbestos-Related Pain Origin from Scientists at the Karmanos Cancer Institute in Detroit

... State University School of Medicine and radiologist at the NCVAC, there was a documented increase in pleural plaques, causing erosion on the interior wall of the ribs. "This action of the pleural plaque against the covering of the bone and the bone itself is a biologically plausible and an ...

Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)

... Canada's Industrial Technologies Office (formerly Technology Partnerships Canada) has contributed to the development of Bioniche's mycobacterial cell wall technologies by means of a C$9.6 million loan that is recoupable from sales. About Bioniche Life Sciences Inc. Bioniche Life ...

Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial

... and expand the addressable market for this innovative technology. These products include: rotator cuff repair, wound care applications and abdominal wall reconstruction; Osteotech estimates that this expanded addressable market opportunity will eventually be in excess of $1 billion yearly. "We ...

vProtect(TM) Luminal Shield Stabilizes Vulnerable Plaque

... "In the future, we hope that the Shield will be used to stabilize these soft, rupture-prone lesions without causing excessive injury to the vessel wall like traditional balloon-expandable stents. We are very encouraged by the healthy endothelial tissue coverage and reduced stenosis demonstrated in ...

Boston Scientific Launches Third-Generation Platinum Chromium Drug-Eluting Stent

... This DES employs the Labcoat technology, which has an ultra thin biodegradable abluminal polymer that delivers a very low dose of paclitaxel to the wall of the treated vessel, and no polymer or drug on the inner surface of the stent. Integrating the Element Stent architecture and a platinum chromium ...

Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative

... is removed through the vagina, a thin, flexible snake-like device, called an endoscope, is inserted through a small incision in the vaginal wall and into the abdomen. Currently, laparoscopic assistance is used as a small camera is also inserted through an incision made in the patient's belly ...

Rosetta Genomics Reports First Ever In-Vivo Efficacy Data for a Systemic MicroRNA Therapeutic for Liver Cancer

... mets, and miRview(TM) meso, are commercially available through its Philadelphia-based CLIA-certified lab. Rosetta Genomics is the 2008 winner of wall Street Journal's Technology Innovation Awards in the medical/biotech category. About MicroRNA MicroRNAs (miRNAs) are recently ...

Cardiac Disease in Women Remains Untreated for Decades

... NEW YORK, Jan. 26 /PRNewswire-USNewswire/ -- Hypertrophic Cardiomyopathy (HCM) is a genetic heart disease that creates a thickening of the heart wall muscle and is the leading cause of sudden cardiac death in children and young adults (<40). More importantly, although heart disease is the ...

Stents Can Treat - Not Just Prevent - Strokes, Suggests Early Research

... improvement in their stroke symptoms. Clot-busting drugs only work about half of the time because the blockage can be sticky and adhere to the wall of the artery, making it difficult to break up, said Dr. Hopkins. Researchers used computed tomography (CT) perfusion to determine if the use ...

Osteotech Initiates Pivotal Clinical Trial for DuraTech(TM) BioRegeneration Matrix

... patient needs and expand the addressable market for this innovative technology, including: rotator cuff repair, wound care applications and abdominal wall reconstruction. About DuraTech(TM) BioRegeneration Matrix Utilizing Osteotech's collagen technology, DuraTech is an engineered ...

GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009.

... milk, or colostrums containing M. paratuberculosis microorganisms. Once ingested, M. paratuberculosis survive and replicate within macrophages in the wall of the intestine and in regional lymph nodes. After an incubation period of several years, extensive granulomatous inflammation occurs in the ...

National Study Presented at ACG 2008 Confirms New Device Functions Like 'Rear-View Mirror' to Provide Improved View of the Colon

... best method available for colorectal cancer screening, we know that lesions may be missed, especially if they are located behind folds in the colon wall and behind flexures, or tight turns in the colon," said Scott Dodson, CEO of Avantis Medical Systems, Inc., developer of the Third Eye Retroscope. ...

QuatRx Pharmaceuticals Announces Additional Data From Phase 3 Study for Ophena(TM) (Ospemifene Tablets) Showing Improvements in Clinical Symptoms of Vulvovaginal Atrophy

... intercourse), two of the most bothersome symptoms associated with VVA. The study also demonstrated favorable effects of Ophena(TM) on vaginal wall health as compared to placebo, measured as changes in the proportion of parabasal and superficial cells in the vaginal epithelium, as well as a ...

Bioheart Reports Promising Results From Preclinical Study of Adipose-Derived Acute Cell Therapy

... circulating blood to the myocardium (heart). This results from the clogging of an artery, potentially due to a build-up of cholesterol in the inner wall of blood vessels that distribute blood to the heart muscle, or thrombosis (clot). This can lead to a part of the heart muscle becoming permanently ...

Pivotal National Trial Uses Newest Interventional Radiology Treatment to Bust Blood Clots in Legs

... blood thinners do not dissolve the existing clot, which remains in the leg. While many patients' clots will slowly dissolve over time, often the vein wall and vein valves become irreversibly damaged in the process. "PTS develops as a direct result of having the blood clot stay in the vein. The blood ...

Stem Cell Regeneration Repairs Congenital Heart Defect

... poor survival, is typical of patients with heritable dilated cardiomyopathy. Researchers transplanted 200,000 embryonic stem cells into the wall of the left ventricle of the knockout mice. After one month the treatment improved heart performance, synchronized electrical impulses and ...

Dr. Ari Kiev to be Featured Speaker at Biotechnology Conference Wall Street Unplugged: The Trout Group Investor Seminar in New York July 30

... Fifth Avenue in New York. The event is targeted to CEOs and CFOs at private and small and mid-cap life science companies to gain better insight into wall Street and maximize communication with the investment community. Dr. Kiev, a peak performance strategist and author of six books on trading ...

Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis

... of a clot, or thrombus, inside a blood vessel that restricts the flow of blood. The formation of a thrombus is often caused by an injury to the wall of a blood vessel. The injury to the blood vessel activates platelets, which then aggregate and adhere to one another as they start to release ...

Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms

... material is intended for use with large aneurysms or those having wide openings, called "necks." Aneurysms form when a weakness in a blood vessel wall causes the vessel to balloon out and form a thin-walled, blood-filled pouch. If this pouch, or sac, develops in a brain blood vessel and bursts, a ...

The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards

... with great care; and is done with special concern for the ethical treatment of the animal." The 2008 winners are as follows: Gautam Naik of The wall Street Journal, Marie McCullough of The Philadelphia Inquirer, Academy Awards nominated directors Steven Ascher and Jeanne Jordan, Richard Ingham and ...

Quatrx Pharmaceuticals Presents Results From Ophena(TM) (Ospemifene Tablets) Phase 3 Study Related to Treatment of Symptoms of Vulvovaginal Atrophy

... improvements in each of these symptoms. Women treated with this dose of Ophena(TM) also showed a favorable effect on the health of their vaginal wall cells as compared to the placebo. There was an average 30 percent decrease in parabasal cells (which indicate an atrophic state) as compared to an ...

New Study Shows BENICAR(R) (olmesartan medoxomil) Reverses Blood Vessel Damage Independent of Blood Pressure Lowering

... early blockade of angiotensin II, improved the structure abnormalities of resistance arteries in patients with hypertension as measured by arterial wall to lumen ratio (W/L), returning arterial architecture to normal levels after one year of treatment. This protective effect was not seen with the ...

Tengion Scientists Publish Key Preclinical Findings Demonstrating the Benefits of Organ Regeneration Vs. Repair

... restored baseline urodynamics as early as six months after implantation and led to a structurally and functionally complete regenerated bladder wall as early as nine months. In contrast, scaffold implants alone failed to return to urodynamic baseline by the study termination and failed to ...

International Symposium on Malignant Mesothelioma 2008

... meso patients, families and caregivers. A tribute ceremony will be held memorializing those who passed away with the unveiling of a tribute wall listing their names. To register for the Symposium and detailed program information, visit http://www.curemeso.org . ...

New Eloxatin(R) (oxaliplatin injection) Prescribing Information in the U.S. Includes Six-Year Overall Survival Data

... safety, including long-term adverse effects. About Colorectal Cancer Stage II colorectal cancer indicates that the cancer has grown through the wall of the colon or rectum but has not yet spread to nearby lymph nodes. At Stage III, the cancer has invaded one or more of the local lymph nodes but ...

PTC Therapeutics Announces Data Supporting Cough Frequency as a New Outcome Measure in Evaluating Treatments for Cystic Fibrosis

... benefit. Quantitative measurement was achieved using a new technology, the VivoMetrics(R) LifeShirt(R), which integrates cough signals from chest wall motion transducers and a throat microphone and stores the data for computer analysis. FEV1 (Forced Expiratory Volume in the first second) and FVC ...

Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers

... since 2004, currently is conducting a European trial evaluating suture products based on TephaFLEX(R) fiber in 150 patients undergoing abdominal wall repair procedures. The results of this trial will be submitted to European regulatory authorities to support Aesculap's application for CE ...

RSV Researcher Makes Gains in Finding Treatments

... one of DeVincenzo's study patients at Le Bonheur. DeVincenzo's GEMINI study's results and their potential impact on human health were reviewed in the wall Street Journal in early March. The next stage in developing the treatment will be to conduct Phase II trials in naturally infected adult ....

Hope for Emphysema Sufferers: Clinical Trial That May Help Patients Breathe Easier Begins at Central DuPage Hospital

... substantial relief to the millions who struggle with each breath." During the airway bypass procedure, new openings are created in the airway wall connecting the damaged lung tissue to the natural airway. These pathways are supported and kept open by Exhale(R) Drug-Eluting Stents manufactured by ...

CorMatrix(R) Announces Intramyocardial Injection of Emulsified ECM Technology(TM) Demonstrates Enhanced Angiogenesis and Improved Cardiac Function in a Preclinical Model

... volume (0.3 +/- 0.1 vs. 0.6 +/- 0.3 ml), fractional shortening (33 +/- 5 vs. 24 +/- 6%) and ejection fraction (67 +/- 6 vs. 53 +/- 10%). The wall thickness of the infarcted middle anterior septum in the injected group was also statistically greater than that in the control (0.19 +/- 0.02 vs. ...

Stenting Techniques Vie in Branchpoint Lesions

... artery. When the stent in the main artery is expanded, it completely covers and crushes the protruding segment of the side-branch stent against the wall of the main artery. For the study, Dr. Gunnes and his colleagues recruited 425 patients with bifurcation lesions, randomly assigning them to ...

Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Bioniche Life Sciences Inc.

... financial models. The EIO(R) presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the wall Street financial community. The EIO(R) details a company's product/technology/service offerings, market size(s), key intellectual property, ...

Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm

... that is not found with implantable coils. A cerebral aneurysm is a swelling of an artery in the brain. As the swelling increases the blood-vessel wall weakens and can rupture, causing bleeding and death. It is estimated that over 30,000 patients in the U.S. are diagnosed with cerebral aneurysms each ...

Inclusion of Six-Year Overall Survival Data in the Eloxatin(R) (oxaliplatin injection) Prescribing Information Granted FDA Priority Review

... benefit in overall survival after a median follow-up of four years. About Colorectal Cancer At Stage II, the cancer has grown through the wall of the colon or rectum but has not yet spread to nearby lymph nodes. In Stage III, the cancer has invaded one or more of the local lymph nodes but ...

BioVascular Inc. Closes $10.87 Million Series C Financing

... medicinalis) and currently produced as a recombinant protein in yeast. The polypeptide is designed to be applied to the inner surface of the arterial wall during surgery. There, it coats exposed collagen fibrils and inhibits the binding of platelets to those fibrils. By blocking platelet adhesion, ...

Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial

... of a clot, or thrombus, inside a blood vessel that restricts the flow of blood. The formation of a thrombus is often caused by an injury to the wall of a blood vessel. The injury to the blood vessel activates platelets, which then aggregate and adhere to one another as they start to release ...

VIA Pharmaceuticals Enrolls First Patient in Phase 2 Clinical Trial to Measure Impact of VIA-2291 to Reduce Vascular Inflammation

... a recent heart attack, and includes measures of leukotrienes, biomarkers of inflammation as well as medical imaging of the coronary vessel wall to evaluate impact on plaque characteristics. About VIA-2291 VIA-2291 is a selective and reversible inhibitor of 5-LO, which is a key enzyme in ...